12-06-2018 07:53 PM CET - Business, Economy, Finances, Banking & Insurance
Print

Rivaroxaban Market Size by Global Industry Analysis 2018 and Forecast to 2023 by Revenue, Type, Application, Growth and Top Key Players: Bayer, J&J

Press release from: Report Hive Research

Over the next five years Rivaroxaban will register a 9.4% CAGR in terms of revenue, reach US$ 10100 million by 2023, from US$ 5860 million in 2017.

Global “Rivaroxaban Market” peaks the detailed analysis of industry share, growth factors, development trends, size, majors manufacturers and 2023 forecast. The report also analyze innovative business strategies, value added factors and business opportunities. The Rivaroxaban Market report introduces market competition situation among the vendors and company profile, revenue, product & services, latest developments and business strategies.

Rivaroxaban is an oral anticoagulant invented and manufactured by Bayer; in a number of countries it is marketed as Xarelto. In the United States, it is marketed by Janssen Pharmaceutica. It is the first available orally active direct factor Xa inhibitor. Rivaroxaban is well absorbed from the gut and maximum inhibition of factor Xa occurs four hours after a dose. The effects last approximately 8–12 hours, but factor Xa activity does not return to normal within 24 hours so once-daily dosing is possible.

The global average price of Rivaroxaban is in the decreasing trend, from 5.62 USD/Unit in 2011 to 5.34 USD/Unit in 2015. With the situation of global economy, prices will be in slowly decreasing trend in the following five years.

Download PDF Sample Of this Report @ www.reporthive.com/enquiry.php?id=1656050&req_type=smpl

Bayer is the only supplier of Rivaroxaban enjoying production market share100% in 2015 and it will still in this situation until 2023.

Rivaroxaban report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

The Key Players Covered in this report:
• Bayer
• J&J and More....

Key Questions Answered in this Report

• What will the market size be in 2023 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?

Segmentation by product type:
• 2.5 mg
• 10 mg
• 15 mg
• 20 mg

Segmentation by application:
• Acute Coronary Syndrome (ACS)
• Venous Thromboembolism (VTE)

Click Here for Purchase Full Report with Full TOC @ www.reporthive.com/enquiry.php?id=1656050&req_type=purch

If you have any special requirements, please let us know and we will offer you the report as you want.

Research objectives
• To understand the structure of Rivaroxaban market by identifying its various subsegments.
• Focuses on the key global Rivaroxaban manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Rivaroxaban with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). and More…

Table of Contents
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Rivaroxaban Consumption 2013-2023
2.1.2 Rivaroxaban Consumption CAGR by Region
2.2 Rivaroxaban Segment by Type

3 GLOBAL RIVAROXABAN BY PLAYERS
3.1 Global Rivaroxaban Sales Market Share by Players
3.1.1 Global Rivaroxaban Sales by Players (2016-2018)
3.1.2 Global Rivaroxaban Sales Market Share by Players (2016-2018)
3.2 Global Rivaroxaban Revenue Market Share by Players
TOC Continued….!

Tables And Figures
• Figure Picture of Rivaroxaban
• Table Product Specifications of Rivaroxaban
• Figure Rivaroxaban Report Years Considered
• Figure Market Research Methodology
• Figure Global Rivaroxaban Consumption Growth Rate 2013-2023 (M Units) and More….

About Report Hive Research
Report Hive Research delivers strategic market research reports, statistical survey, and Industry analysis & forecast data on products & services, markets and companies. Our clientele ranges mix of global Business Leaders, Government Organizations, SME’s, Individual & Start-ups, Management Consulting Firms, and Universities etc. Our library of 600,000+ market reports covers industries like Chemical, Healthcare, IT, Telecom, Semiconductor, etc. in the USA, Europe Middle East, Africa, Asia Pacific. We help in business decision-making on aspects such as market entry strategies, market sizing, market share analysis, sales & revenue, technology trends, competitive analysis, product portfolio & application analysis etc.

500, North Michigan Avenue,
Suite 6014
Chicago, IL - 60611
United States

Contact Us
Mike Ross
Marketing Manager
sales@reporthive.com
www.reporthive.com
Phone Number: +1-312 604 7084

This release was published on openPR.
News-ID: 1423238 • Views: 143
More releasesMore releases

You can edit or delete your press release here: